AngioDynamics News

AngioDynamics Analyst Ratings

BenzingaApr 5 08:39 ET

AngioDynamics Stock Upgraded by Oppenheimer on FDA Approval, Strong Balance Sheet

InvestingApr 5 08:16 ET

Buy Rating Reaffirmed for AngioDynamics Amidst Strategic Growth and Med-Tech Sector Potential

TipRanksApr 5 06:56 ET

Analysts' Top Healthcare Picks: AngioDynamics (ANGO), Corcept Therapeutics (CORT)

TipRanksFeb 16 06:20 ET

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $10

BenzingaJan 9 05:07 ET

AngioDynamics Analyst Ratings

BenzingaJan 9 05:06 ET

Oppenheimer Keeps Their Hold Rating on AngioDynamics (ANGO)

TipRanksJan 8 07:55 ET

HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18

BenzingaJan 8 06:33 ET

AngioDynamics Analyst Ratings

BenzingaJan 8 06:32 ET

Buy Rating Maintained for AngioDynamics Amidst Strategic Restructuring and New Product Launches

TipRanksJan 8 06:26 ET

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12

BenzingaOct 6, 2023 04:16 ET

Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $17

BenzingaOct 5, 2023 14:30 ET

AngioDynamics Analyst Ratings

BenzingaOct 5, 2023 14:29 ET

HC Wainwright & Co. Maintains Buy on AngioDynamics, Raises Price Target to $20

BenzingaOct 5, 2023 07:12 ET

AngioDynamics Analyst Ratings

BenzingaOct 5, 2023 07:11 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: AngioDynamics (ANGO), Ionis Pharmaceuticals (IONS) and Akero Therapeutics (AKRO)

TipRanksOct 5, 2023 06:31 ET

Analysts Offer Insights on Healthcare Companies: AngioDynamics (ANGO), Enlivex (ENLV) and Relmada Therapeutics (RLMD)

TipRanksSep 25, 2023 06:20 ET

AngioDynamics Analyst Ratings

BenzingaSep 25, 2023 06:13 ET

AngioDynamics Analyst Ratings

BenzingaJul 13, 2023 10:52 ET

Barrington Raises Price Target on Merit Medical Systems to $95 From $90 Amid Acquisition of Assets From AngioDynamics and Bluegrass Vascular, Reiterates Outperform Rating

MT NewswiresJun 9, 2023 09:14 ET